Skip to content
Southern Research Home
Services
By Therapeutic Area
Infectious Disease Research
Infectious Disease Research
Oncology
Oncology
Emerging & Rare Disease Initiatives
Emerging & Rare Disease Initiatives
By Capability
View All
Chemistry
Chemistry
ADME & In Vitro Toxicology
ADME & In Vitro Toxicology
High-Throughput Screening & Discovery
HTS
Bioanalytical Services
Bioanalytical Services
Animal Models
Animal Models
In Vivo Toxicology
In Vivo Toxicology
Pathology
Pathology
Biosafety Level 3 (BSL 3) Services
Biosafety Level 3 (BSL 3) Services
Therapeutic Modalities
Therapeutic Modalities
Clinical Trial Sample Analysis
Clinical Trial Sample Analysis
About
About Us
Executive Leadership
Meet Our Team
History
STEM
UAB Affiliation
Station 41
Catalyst
Resources
News
Careers
Contact Us
Open Menu
Close Menu
Alan Spear
Alan Spear, CPA
Chief Financial Officer
Services
View All
By Therapeutic Area
Infectious Disease Research
Infectious Disease Research
Oncology
Oncology
Emerging & Rare Disease Initiatives
Emerging & Rare Disease Initiatives
By Capability
Chemistry
Chemistry
ADME & In Vitro Toxicology
ADME & In Vitro Toxicology
High-Throughput Screening & Discovery
HTS
Bioanalytical Services
Bioanalytical Services
Animal Models
Animal Models
In Vivo Toxicology
In Vivo Toxicology
Pathology
Pathology
Biosafety Level 3 (BSL 3) Services
Biosafety Level 3 (BSL 3) Services
Therapeutic Modalities
Therapeutic Modalities
Clinical Trial Sample Analysis
Clinical Trial Sample Analysis
About
About Us
Executive Leadership
Meet Our Team
History
STEM
UAB Affiliation
Station 41
Catalyst
Resources
News
Careers
Contact Us
